Why Do Women with Mesothelioma Survive Longer than Men?
Researchers at Brigham and Women’s Hospital are trying to answer that question so they can extend survival for all mesothelioma patients.
Immunotherapy Vaccine for Mesothelioma Gets High Marks
Researchers say immunotherapy vaccine CRS-207 may soon become a standard-of-care treatment for mesothelioma.
Univ. of Hawaii Awarded $3M Mesothelioma Research Grants
The U.S. Department of Defense multiyear grants will advance mesothelioma research at the University of Hawaii Cancer Center.
Exclusive: Quincy Jones Talks Mesothelioma & Comedy
Comedian Quincy Jones talks to Asbestos.com about how he’s using his upcoming HBO comedy special to raise mesothelioma awareness.
Indiana Asbestos Case: Good News for Mesothelioma Patients
The Indiana Supreme Court struck down part of a state law that victimized mesothelioma patients and asbestos victims.
New Immunotherapy Center Raises Hopes for Mesothelioma
Johns Hopkins’ Bloomberg–Kimmel Institute for Cancer Immunotherapy in Baltimore will advance mesothelioma treatment.
WT1 Vaccine Nears Approval as Second-Line Mesothelioma Treatment
Researchers are hopeful the immunotherapy vaccine will be the first to provide treatment for mesothelioma when standard therapies fail.
Mesothelioma Clinical Trial Explores Surgery with Immunotherapy
Baylor College of Medicine in Houston began enrolling participants for the mesothelioma surgery and immunotherapy clinical trial last week.
Comedian Quincy Jones Has Mesothelioma, Lands HBO special
HBO will air the stand-up comedian’s one-hour special later this spring. His mesothelioma diagnosis will likely raise awareness of the disease.
New Mesothelioma Immunogene Clinical Trial Set to Launch
Mesothelioma specialist Dr. Dan Sterman says the clinical trial promises to extend patients’ lives and improve their quality of life.
Garlock, EnPro Reach $480M Settlement for Asbestos Claims
EnPro Industries agreed to the multimillion-dollar settlement of Garlock asbestos claims against the company’s bankruptcy trust fund.
Improving Mesothelioma Survival by Targeting New Genetic Mutations
Mesothelioma specialist Dr. David Sugarbaker of Baylor College of Medicine says discovery is a home run in mesothelioma treatment.
Moffitt Launches New Mesothelioma Clinical Trials in Tampa
New clinical trials focusing on chemoperfusion and antibody treatments show promise for mesothelioma patients.
Tremelimumab Failed to Extend Mesothelioma Survival Rates
Researchers halted the tremelimumab clinical trial because the immunotherapy drug didn’t benefit mesothelioma patients.
Johnny Lattner: Heisman Winner and Steeler Dies of Mesothelioma
Former Pittsburgh Steeler Johnny Lattner has died of mesothelioma linked to asbestos exposures in the U.S. Air Force and various summer jobs in college.